"Does addition of N-acetyl cysteine, as an adjunct to beta-blocker therapy, decrease the incidence of postcoronary artery bypass atrial fibrillation?" by Katarzyna Jabbour, PharmD, BCPS

Article

Does addition of N-acetyl cysteine, as an adjunct to beta-blocker therapy, decrease the incidence of postcoronary artery bypass atrial fibrillation?

Evidence-Based Practice

Katarzyna Jabbour, PharmD, BCPS, Lehigh Valley Health Network
Ashwini Kamath Mulki, MD, Lehigh Valley Health Network
Drew Keister, MD, Lehigh Valley Health Network
Robert Motley, MD, Lehigh Valley Health Network

Link

Publication/Presentation Date

1-1-2018

Disciplines

Family Medicine

Document Type

Article

Citation Information

Jabbour, K. Mulki, A. Keister, D. Motley, R. (2018). Does addition of N-acetyl cysteine, as an adjunct to beta-blocker therapy, decrease the incidence of postcoronary artery bypass atrial fibrillation?. Evidence-Based Practice.